Fibronexus in "malignant fibrous histiocytoma" of the bone: A case report of pleomorphic myofibrosarcoma

被引:17
作者
Watanabe, K [1 ]
Ogura, G [1 ]
机构
[1] Fukushima Med Univ, Sch Med Hosp, Div Pathol, Fukushima 9601295, Japan
关键词
bone tumor; fibronexus; histiocytoma; myofibroblast; myofibrosarcoma;
D O I
10.1080/01913120252934332
中图分类号
TH742 [显微镜];
学科分类号
摘要
The fibronexus (fibronexus junction) has been thought to be a characteristic ultrastructural feature of myofibroblasts, but it is controversial whether the fibronexus is also a characteristic of various myofibroblastic tumors. We report here a case of pleomorphic bone sarcoma (pleomorphic/storiform malignant fibrous histiocytoma) with fibronexus junctions arising in the head of the left humerus of a 70-year-old woman. By light microscopy the tumor was composed of large spindle or polygonal cells occasionally arranged in fascicles. Foamy giant cells with bizarre nuclei were not uncommon. Immunohistochemically, the tumor cells were positive diffusely for vimentin and focally for muscle actin (HHF35) and alpha-smooth muscle actin but were negative for desmin, high-molecular weight caldesmon, and S-100 protein. Ultrastructurally, the tumor cells had indented nuclei and spindle or polygonal cytoplasm, with little rough endoplasmic reticulum and small vesicles, and rather numerous mitochondria. The tumor cells had myofilaments with focal densities in the periphery, fibronectin fibrils adjacent to intracellular myofilaments, and by definition, therefore, fibronexus junctions. These findings suggest myofibroblastic differentiation, and a diagnosis of pleomorphic myofibrosarcoma is thought to be appropriate. We believe that the fibronexus is a characteristic and useful ultrastructural feature for differentiating myofibroblastic tumors from other pleomorphic myogenic sarcomas.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 33 条
[1]  
BHAWAN J, 1979, AM J PATHOL, V94, P19
[2]  
CAPANNA R, 1984, CANCER-AM CANCER SOC, V54, P177, DOI 10.1002/1097-0142(19840701)54:1<177::AID-CNCR2820540133>3.0.CO
[3]  
2-C
[4]   Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study [J].
Ceballos, KM ;
Nielsen, GP ;
Selig, MK ;
O'Connell, JX .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (05) :746-753
[5]  
Chan JKC., 1996, Adv Anat Pathol, V3, P156
[6]  
Coffin CM, 1998, SEMIN DIAGN PATHOL, V15, P102
[7]   EXTRAPULMONARY INFLAMMATORY MYOFIBROBLASTIC TUMOR (INFLAMMATORY PSEUDOTUMOR) - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 84 CASES [J].
COFFIN, CM ;
WATTERSON, J ;
PRIEST, JR ;
DEHNER, LP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (08) :859-872
[8]   The myofibroblast: An assessment of controversial issues and a definition useful in diagnosis and research [J].
Eyden, B .
ULTRASTRUCTURAL PATHOLOGY, 2001, 25 (01) :39-50
[9]  
Eyden B, 2001, HISTOL HISTOPATHOL, V16, P57, DOI 10.14670/HH-16.57
[10]   A STUDY OF SPINDLE CELL SARCOMAS SHOWING MYOFIBROBLASTIC DIFFERENTIATION [J].
EYDEN, BP ;
BANERJEE, SS ;
HARRIS, M ;
MENE, A .
ULTRASTRUCTURAL PATHOLOGY, 1991, 15 (4-5) :367-378